肥胖患者尿道成形术后的早期术后事件:多机构回顾性系列研究
该多机构回顾性系列研究比较了非肥胖、肥胖和病态肥胖患者因尿道狭窄行尿道成形术的早期结局。2016年1月至2020年12月期间在5家机构接受尿道成形术的201例患者被纳入分析,肥胖患者更多为前尿道、医源性和LS相关狭窄,但肥胖与并发症、造影剂渗漏、二次干预或复发无关,肥胖患者失血量更多且住院时间更长。作者认为尿道成形术在肥胖患者中是安全有效的。
要点
- 肥胖患者更多为前尿道、医源性和LS相关狭窄(P<.001,P=.036)。
- 60天并发症率为26.3%,各体重组间无差异(P=.788)。
- 肥胖患者估计失血量更多(P=.001)且住院时间更长(P=.001)。
核心结论
- 肥胖与并发症、造影剂渗漏、二次干预或复发无关。
- 肥胖患者失血量更多且住院时间更长。
- 作者认为尿道成形术在肥胖患者中是安全有效的。
研究设计与样本
- 多机构回顾性系列研究,纳入2016年1月至2020年12月期间在5家机构接受尿道成形术的201例患者。
- 肥胖(BMI 30-39.9,n=72)和病态肥胖(BMI>40,n=49)患者与正常体重(BMI<25,n=29)和超重(BMI 25-29.9,n=51)患者进行比较。
- 采用单因素和多因素分析比较并发症、复发和二次干预等结局。
主要发现
- 201例患者平均BMI 34.1(范围18.4-65.2),平均年龄52.2岁(SD=17.2),中位随访时间3.71个月。
- 肥胖患者更年轻(P=.008),更多为前尿道狭窄(P<.001),更多为医源性和LS相关狭窄(P=.036)。
- 60天并发症率为26.3%,各队列间无差异(P=.788)。
- 约9.5%的患者在拔除导管时出现造影剂外渗,18.9%报告狭窄复发,7.4%需要额外干预。
- 肥胖患者估计失血量更多(P=.001)且住院时间更长(P=.001)。
临床怎么用
- 作者认为尿道成形术在肥胖患者中是安全有效的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare early urethroplasty outcomes in non-obese, obese and morbidly obese patients undergoing urethroplasty for urethral stricture disease. The impact of obesity on outcomes is poorly understood but will be increasingly important as obesity continues to rise. METHODS: Patients underwent urethroplasty at one of the 5 institutions between January 2016 and December 2020. Obese (BMI 30-39.9, n = 72) and morbidly obese (BMI >40, n = 49) patients were compared to normal weight (BMI <25, n = 29) and overweight (BMI 25-29.9, n = 51) patients. Demographics, comorbidities, and stricture characteristics were collected. Outcomes including complications, recurrence, and secondary interventions were compared using univariate and multivariate analysis. RESULTS: Two hundred and one patients (Mean BMI 34.1, Range 18.4-65.2) with mean age 52.2 years (SD=17.2) were analyzed. Median follow-up time was 3.71 months. Obese patients were younger (P = .008), had more anterior (P <.001), iatrogenic and LS-associated strictures (P = .036). Sixty-day complication rate was 26.3% with no differences between cohorts (P = .788). Around 9.5% of patients had extravasation at catheter removal, 18.9% reported stricture recurrence, and 7.4% required additional interventions. Obese patients had greater estimated blood loss (P = .001) and length of stay (P = .001). On multivariate analysis, smoking associated with contrast leak (OR 7.176, 95% CI 1.13-45.5) but not recurrence or need for intervention (P = .155, .927). CONCLUSION: Obese patients in our cohort had more anterior, iatrogenic, and LS-related strictures. However, obesity is not associated with complications, contrast leak, secondary interventions, or recurrence. Obese had higher blood loss and length of stay. Urethroplasty is safe and effective in obese patients.
引用
- Patrick Mershon J, Bennett J, Murtha M, et al. Early Post-Operative Events After Urethroplasty in Obese Patients: A Multi-Institutional Retrospective Series. Urology. 2024. PMID: 38754790. doi:10.1016/j.urology.2024.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。